However, in the context of melanoma, MALT1 knockdown also suppresses activation of the JNK/AP-1 signaling pathway, indicating that the cellular effects observed upon MALT1 protease inhibition might not be attributable solely to the specific downregulation of NF-κB. The gene discussed is NFKB1; the disease is melanoma.